reported the plasma cholesterol lowering effects of some other mushrooms in experimental rats. The decrease in cholesterol concentration was not limited to the plasma but also present in the liver after Ganoderma lucidum feeding (Table  3) . It has been reported that the liver cholesterol levels in SHRs were signifi cantly higher than that of the corresponding normotensive rats (15). The high cho lesterol level in the livers of our control SHRs was in agreement with that report. The consistent relationship between plasma and liver cholesterol levels suggests that the alterations in plasma cholesterol level is not entirely ascribable to the transpor tation of cholesterol between the liver and the plasma under our experimental conditions. A low plasma and liver cholesterol level in Ganoderma lucidum-fed animals may be due to the inhibition in cholesterol synthesis and/or acceleration of cholesterol metabolism. Although the exact mechanism for these effects was not known, our results suggest that an appropriate dietary manipulation may prevent the increase of blood pressure and reduce plasma and liver cholesterol levels in SHRs.
